PRINCIPAL FINANCIAL GROUP INC

Position in MIRM — Mirum Pharmaceuticals, Inc.

CIK 1126328 DES MOINES, IA

Position in MIRM

as of Jun 30, 2026 · filed Aug 4, 2026 Compact

Position Value

$11,929,432

+$6,629,685 QoQ

Shares Held

101,900

+77.6% QoQ

Ownership

0.157%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#83

of 327 holders

Holding Since

Jun 2022

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

PRINCIPAL FINANCIAL GROUP INC holds $1,852,088,599 across 105 Biotechnology names. MIRM ranks #33 (0.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ASND	Ascendis Pharma A/S	873,502	$232,980,453
2	VRTX	Vertex Pharmaceuticals Inc / Ma	389,511	$193,481,798
3	CYTK	Cytokinetics Inc	1,311,664	$111,740,655
4	GPCR	Structure Therapeutics Inc.	1,752,753	$94,070,253
5	INSM	INSMED Inc	856,126	$91,280,154
6	AXSM	Axsome Therapeutics, Inc.	332,642	$81,420,782
7	BBIO	BridgeBio Pharma, Inc.	1,024,423	$76,299,024
8	REGN	Regeneron Pharmaceuticals, Inc.	121,053	$75,481,386

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$11,929,432	101,900	+77.6%	Shares	Defined	2026-08-04
2026-03-31	$5,299,747	57,369	+81.2%	Shares	Defined	2026-05-04
2025-12-31	$2,500,743	31,659	+41.1%	Shares	Defined	2026-02-02
2025-09-30	$1,645,075	22,440	-28.6%	Shares	Defined	2025-11-04
2025-06-30	$1,598,962	31,420	+348.8%	Shares	Defined	2025-08-08
2024-06-30	$239,363	7,001	-15.9%	Shares	Defined	2024-07-29
2024-03-31	$209,173	8,327	+1.3%	Shares	Defined	2024-04-29
2023-12-31	$242,742	8,223	-1.1%	Shares	Defined	2024-02-07
2023-09-30	$262,627	8,311	-3.7%	Shares	Defined	2023-11-02
2023-06-30	$223,205	8,628	-75.3%	Shares	Defined	2023-08-07
2022-06-30	$680,535	34,971	—	Shares	Defined	2022-08-10
No filing history on record for this holder in this stock.